Search results
PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024
The Pilot News· 1 day agoPAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical
Healthwatch: UVA Health introduces implantable heart defibrillator
WSLS Newschannel 10 Roanoke· 15 hours agoA medical breakthrough out of UVA Health as a team performs the first-of-its kind implantable heart...
Neuromodulation to see market growth, pioneering technology for epilepsy
Medical Device Network via Yahoo Finance· 4 days agoA DBS is a device that comprises a brain-oriented pacemaker (an implantable pulse generator) that...
Senseonics gets FDA clearance to pair CGM implant with insulin pumps
MedTech Dive via Yahoo Finance· 3 days agoSenseonics... analysts said the iCGM designation and planned one-year sensor could help the device...
FDA Allows Implantable CGM to Integrate With Insulin Pumps
Medscape· 3 days agoThe US Food and Drug Administration grants new status to Senseonics' Eversense.
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed...
Benzinga· 2 days agoONWARD Medical N.V. ONWD, a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence ...
AUA/SUFU Guideline on the Treatment of Overactive Bladder Allows Access to Revi™ System Earlier in...
The Yuma Sun· 5 days agoBlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric solution for urge urinary ...
PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University...
FOX 4 Kansas City· 4 days agoPAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device ...
URMC launches landmark study on heart failure treatments
13WHAM Rochester· 4 days agoResearchers at the University of Rochester Medical Center are launching a $27 million study on heart...
FDA Roundup: April 30, 2024
WPRI Providence· 4 days agoOn Monday, the FDA authorized marketing of Sensonics, Inc.'s Eversense AP CGM System that includes a fully implantable sensor with an anti-inflammatory drug (dexamethasone ...